RBC Capital Reiterates Outperform on Starbucks Coffee (SBUX) After Trimming Estimates

Nomura Maintains Bullish View on Starbucks (SBUX) Post Q3

July 22, 2016 8:34 AM EDT

Nomura Securities analyst Mark Kalinowski reiterated a Buy rating and $70 price target on Starbucks (NASDAQ: SBUX) following Q3 results.

Kalinowski commented, "After Thursday's market close, Starbucks (SBUX; Buy) reported adjusted fiscal Q3 EPS of $0.49, matching our $0.49 estimate and the Consensus Metrix number... More

Jefferies Cuts Price Target on Starbucks Coffee (SBUX) Following In-Line Quarter

July 22, 2016 8:18 AM EDT

Jefferies maintained a Buy rating on Starbucks Coffee (NASDAQ: SBUX), and cut the price target to $65.00 (from $70.00) following the company's 3Q earnings report. SBUX reported an in-line EPS. Management maintained 2016 EPS guidance.

Analyst Andy Barish commented, "SBUX eked out an... More

Starbucks Coffee (SBUX): Weak June Comp While Guidance Implies Acceleration - Stifel

July 22, 2016 6:17 AM EDT

Stifel analyst, Mark Astrachan, noted that Starbucks Coffee (NASDAQ: SBUX) reported F3Q16 (June) results with EPS of $0.49, inline with consensus, on 4% global comparable store sales growth (4% ticket and 0% traffic), below consensus of 5.7%. Comp store sales growth in the Americas, the most important metric... More

After-Hours Stock Movers 07/21 (PBYI) (EYES) (PFPT) Higher; (SKX) (ATHN) (P) Lower (more...)

July 21, 2016 5:59 PM EDT

Today's After-Hours Movers

Puma Biotechnology, Inc. (NYSE: PBYI) 18.8% HIGHER; submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate PB272 (neratinib) for the extended adjuvant treatment of patients with early stage HER2-overexpressed/amplified breast cancer who have received prior adjuvant trastuzumab (Herceptin®)-based therapy. Also, announced updated results from the Phase III clinical trial of Pumas investigational drug PB272 (neratinib) for the extended adjuvant treatment of HER2-positive early stage breast cancer (ExteNET trial). The ExteNET trial is a... More

Starbucks cafe sales miss targets as growth cools, stock falls

July 21, 2016 4:20 PM EDT

By Lisa Baertlein

(Reuters) - Starbucks Corp (NASDAQ: SBUX) reported quarterly cafe sales growth that fell short of expectations in all major markets as customers made fewer visits, sending its shares down almost 3 percent on Thursday.

Results from the United States, which contributes the lion's share of sales and profits, missed targets due to the delayed start of a popular Frappuccino Happy Hour promotion and weaker demand that executives attributed to a contentious U.S. presidential election campaign, terrorist attacks and civil unrest.

The world's largest coffee chain reported... More

Starbucks Coffee (SBUX) Reports In-Line Q3 EPS;Global Comps Rose 4%

July 21, 2016 4:06 PM EDT

Starbucks Coffee (NASDAQ: SBUX) reported Q3 EPS of $0.49, in-line with the analyst estimate of $0.49. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.33 billion.

Global comparable store sales increased 4%, comprised of a 4% increase in the Americas segment, a 3%... More

Starbucks Coffee (SBUX) July weekly volatility elevated into Q2 and outlook

July 21, 2016 10:43 AM EDT

Starbucks Coffee (SBUX) July weekly call option implied volatility is at 86, August is at 23; compared to its 52-week range of 17 to 41 into the expected release of Q2 results today after the market close.

... More

Intel, transports sap Wall Street's strength

July 21, 2016 7:12 AM EDT

By Lewis Krauskopf

(Reuters) - Wall Street cooled off on Thursday as disappointing quarterly reports from tech stalwart Intel and from transportation companies stalled momentum in a U.S. corporate earnings season that has been better than feared.

The S&P 500 and Dow industrials pulled back from record highs and the Dow snapped a nine-session streak of gains.

Southwest Airlines (NYSE: LUV) fell 11.2 percent and led other airline stocks lower after the company forecast a drop in a key profitability metric. Union Pacific (NYSE:... More

Trading Radar for 7/21: GM (GM), Chipotle (CMG), AMD (AMD), Starbucks (SBUX), Pandora (P), Visa (V), Travelers (TRV) Report

July 20, 2016 2:39 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 265kContinuing Claims - no Street consensusPhiladelphia Fed - Street sees 5.0

9:00am EDT

FHFA Housing Price Index - no Street consensus

Earnings:

ABB Ltd. (NYSE: ABB) - consensus EPS $0.26
Adeptus Health (NYSE: ADPT) - consensus EPS $0.51
Alaska Air Group (NYSE: ALK) - consensus EPS $2.07... More